Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines

PHASE4CompletedINTERVENTIONAL

Enrollment

387

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

DiphtheriaTetanusPolioPertussisHaemophilus Influenzae Type B

Interventions

BIOLOGICAL

Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccine

0.5 mL, IM

BIOLOGICAL

Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccine

0.5 mL, IM

Trial Locations (1)

Manila